240 related articles for article (PubMed ID: 37016755)
1. Prescription psychostimulants for cocaine use disorder: A review from molecular basis to clinical approach.
Tardelli VS; Berro LF; Gerra G; Tadonio L; Bisaga A; Fidalgo TM
Addict Biol; 2023; 28(4):e13271. PubMed ID: 37016755
[TBL] [Abstract][Full Text] [Related]
2. Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.
Tardelli VS; Bisaga A; Arcadepani FB; Gerra G; Levin FR; Fidalgo TM
Psychopharmacology (Berl); 2020 Aug; 237(8):2233-2255. PubMed ID: 32601988
[TBL] [Abstract][Full Text] [Related]
3. Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence.
Vocci FJ; Montoya ID
Curr Opin Psychiatry; 2009 May; 22(3):263-8. PubMed ID: 19307968
[TBL] [Abstract][Full Text] [Related]
4. Medications to treat cocaine use disorders: current options.
Buchholz J; Saxon AJ
Curr Opin Psychiatry; 2019 Jul; 32(4):275-281. PubMed ID: 31008728
[TBL] [Abstract][Full Text] [Related]
5. Psychostimulant treatment of cocaine dependence.
Mariani JJ; Levin FR
Psychiatr Clin North Am; 2012 Jun; 35(2):425-39. PubMed ID: 22640764
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis.
De Crescenzo F; Ciabattini M; D'Alò GL; De Giorgi R; Del Giovane C; Cassar C; Janiri L; Clark N; Ostacher MJ; Cipriani A
PLoS Med; 2018 Dec; 15(12):e1002715. PubMed ID: 30586362
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of psychostimulant drugs for cocaine dependence.
Castells X; Casas M; Pérez-Mañá C; Roncero C; Vidal X; Capellà D
Cochrane Database Syst Rev; 2010 Feb; (2):CD007380. PubMed ID: 20166094
[TBL] [Abstract][Full Text] [Related]
8. Treatment of stimulant use disorder: A systematic review of reviews.
Ronsley C; Nolan S; Knight R; Hayashi K; Klimas J; Walley A; Wood E; Fairbairn N
PLoS One; 2020; 15(6):e0234809. PubMed ID: 32555667
[TBL] [Abstract][Full Text] [Related]
9. A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders.
Chan B; Freeman M; Ayers C; Korthuis PT; Paynter R; Kondo K; Kansagara D
Drug Alcohol Depend; 2020 Nov; 216():108193. PubMed ID: 32861136
[TBL] [Abstract][Full Text] [Related]
10. The treatment of cocaine use disorder.
Kampman KM
Sci Adv; 2019 Oct; 5(10):eaax1532. PubMed ID: 31663022
[TBL] [Abstract][Full Text] [Related]
11. A sequential multiple assignment randomized trial for cocaine cessation and relapse prevention: Tailoring treatment to the individual.
Schmitz JM; Stotts AL; Vujanovic AA; Weaver MF; Yoon JH; Vincent J; Green CE
Contemp Clin Trials; 2018 Feb; 65():109-115. PubMed ID: 29287664
[TBL] [Abstract][Full Text] [Related]
12. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.
Levin FR; Mariani JJ; Specker S; Mooney M; Mahony A; Brooks DJ; Babb D; Bai Y; Eberly LE; Nunes EV; Grabowski J
JAMA Psychiatry; 2015 Jun; 72(6):593-602. PubMed ID: 25887096
[TBL] [Abstract][Full Text] [Related]
13. Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD.
Manni C; Cipollone G; Pallucchini A; Maremmani AGI; Perugi G; Maremmani I
Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31618876
[No Abstract] [Full Text] [Related]
14. Patterns of reduced use and abstinence in multi-site randomized controlled trials of pharmacotherapies for cocaine and methamphetamine use disorders.
Amin-Esmaeili M; Susukida R; Johnson RM; Farokhnia M; Crum RM; Thrul J; Mojtabai R
Drug Alcohol Depend; 2021 Sep; 226():108904. PubMed ID: 34304121
[TBL] [Abstract][Full Text] [Related]
15. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
Klimas J; Tobin H; Field CA; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C; Cullen W
Cochrane Database Syst Rev; 2014 Dec; (12):CD009269. PubMed ID: 25470303
[TBL] [Abstract][Full Text] [Related]
16. The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States.
Hoots B; Vivolo-Kantor A; Seth P
Addiction; 2020 May; 115(5):946-958. PubMed ID: 31912625
[TBL] [Abstract][Full Text] [Related]
17. Memory-Focused Cognitive Therapy for Cocaine Use Disorder: Theory, Procedures and Preliminary Evidence From an External Pilot Randomised Controlled Trial.
Marsden J; Goetz C; Meynen T; Mitcheson L; Stillwell G; Eastwood B; Strang J; Grey N
EBioMedicine; 2018 Mar; 29():177-189. PubMed ID: 29478874
[TBL] [Abstract][Full Text] [Related]
18. Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.
Jordan CJ; Cao J; Newman AH; Xi ZX
Neuropharmacology; 2019 Nov; 158():107609. PubMed ID: 31009632
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy for Cocaine Use Disorder-a Systematic Review and Meta-analysis.
Chan B; Kondo K; Freeman M; Ayers C; Montgomery J; Kansagara D
J Gen Intern Med; 2019 Dec; 34(12):2858-2873. PubMed ID: 31183685
[TBL] [Abstract][Full Text] [Related]
20. A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone.
Schmitz JM; Green CE; Stotts AL; Lindsay JA; Rathnayaka NS; Grabowski J; Moeller FG
Drug Alcohol Depend; 2014 Mar; 136():100-7. PubMed ID: 24424425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
